189 related articles for article (PubMed ID: 35436062)
1. Current Treatments in Marginal Zone Lymphoma.
Alderuccio JP; Kahl BS
Oncology (Williston Park); 2022 Apr; 36(4):206-215. PubMed ID: 35436062
[TBL] [Abstract][Full Text] [Related]
2. Transformation of marginal zone lymphoma (and association with other lymphomas).
Casulo C; Friedberg J
Best Pract Res Clin Haematol; 2017; 30(1-2):131-138. PubMed ID: 28288708
[TBL] [Abstract][Full Text] [Related]
3. Management of Marginal Zone Lymphoma: A Canadian Perspective.
Peters A; Keating MM; Nikonova A; Doucette S; Prica A
Curr Oncol; 2023 Feb; 30(2):1745-1759. PubMed ID: 36826096
[TBL] [Abstract][Full Text] [Related]
4. Marginal Zone Lymphoma: State-of-the-Art Treatment.
Sindel A; Al-Juhaishi T; Yazbeck V
Curr Treat Options Oncol; 2019 Dec; 20(12):90. PubMed ID: 31807935
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of the Follicular Lymphoma International Prognostic Index score in marginal zone lymphoma: an analysis of clinical presentation and outcome in 144 patients.
Heilgeist A; McClanahan F; Ho AD; Witzens-Harig M
Cancer; 2013 Jan; 119(1):99-106. PubMed ID: 22736411
[TBL] [Abstract][Full Text] [Related]
6. Myeloid cell nuclear differentiation antigen is expressed in a subset of marginal zone lymphomas and is useful in the differential diagnosis with follicular lymphoma.
Metcalf RA; Monabati A; Vyas M; Roncador G; Gualco G; Bacchi CE; Younes SF; Natkunam Y; Freud AG
Hum Pathol; 2014 Aug; 45(8):1730-6. PubMed ID: 24925224
[TBL] [Abstract][Full Text] [Related]
7. Trends in incidence, therapy and outcome of localized nodal and extranodal marginal zone lymphomas: declining incidence and inferior outcome for gastrointestinal sites.
Kuper-Hommel MJ; van de Schans SA; Vreugdenhil G; van Krieken JH; Coebergh JW
Leuk Lymphoma; 2013 Sep; 54(9):1891-7. PubMed ID: 23302044
[TBL] [Abstract][Full Text] [Related]
8. Marginal zone B-cell lymphoma: A clinical comparison of nodal and mucosa-associated lymphoid tissue types. Non-Hodgkin's Lymphoma Classification Project.
Nathwani BN; Anderson JR; Armitage JO; Cavalli F; Diebold J; Drachenberg MR; Harris NL; MacLennan KA; Müller-Hermelink HK; Ullrich FA; Weisenburger DD
J Clin Oncol; 1999 Aug; 17(8):2486-92. PubMed ID: 10561313
[TBL] [Abstract][Full Text] [Related]
9. Marginal zone lymphomas.
Zucca E; Rossi D; Bertoni F
Hematol Oncol; 2023 Jun; 41 Suppl 1():88-91. PubMed ID: 37294969
[TBL] [Abstract][Full Text] [Related]
10. Leukaemic subtype of marginal zone lymphoma: a presentation of three cases and literature review.
Tam CS; Prince HM; Westerman D; Seymour JF; Juneja S
Leuk Lymphoma; 2004 Apr; 45(4):705-10. PubMed ID: 15160943
[TBL] [Abstract][Full Text] [Related]
11. Follicular lymphoma and marginal zone lymphoma: how many diseases?
Laurent C; Cook JR; Yoshino T; Quintanilla-Martinez L; Jaffe ES
Virchows Arch; 2023 Jan; 482(1):149-162. PubMed ID: 36394631
[TBL] [Abstract][Full Text] [Related]
12. Contemporary management of nodal and primary splenic marginal zone lymphoma.
Leslie LA; Feldman TA; McNeill A; Timberg M; Iida H; Goy AH
Expert Rev Hematol; 2019 Dec; 12(12):1011-1022. PubMed ID: 31619091
[No Abstract] [Full Text] [Related]
13. Primary follicular and marginal-zone lymphoma of the breast: clinical features, prognostic factors and outcome: a study by the International Extranodal Lymphoma Study Group.
Martinelli G; Ryan G; Seymour JF; Nassi L; Steffanoni S; Alietti A; Calabrese L; Pruneri G; Santoro L; Kuper-Hommel M; Tsang R; Zinzani PL; Taghian A; Zucca E; Cavalli F
Ann Oncol; 2009 Dec; 20(12):1993-9. PubMed ID: 19570964
[TBL] [Abstract][Full Text] [Related]
14. Clinical presentation and management of marginal zone lymphomas.
Thieblemont C
Hematology Am Soc Hematol Educ Program; 2005; ():307-13. PubMed ID: 16304396
[TBL] [Abstract][Full Text] [Related]
15. Front-line management of indolent non-Hodgkin lymphoma in Australia. Part 2: mantle cell lymphoma and marginal zone lymphoma.
Cheah CY; Opat S; Trotman J; Marlton P
Intern Med J; 2019 Sep; 49(9):1070-1080. PubMed ID: 30816618
[TBL] [Abstract][Full Text] [Related]
16. Marginal zone lymphoma: 2023 update on diagnosis and management.
Cheah CY; Seymour JF
Am J Hematol; 2023 Oct; 98(10):1645-1657. PubMed ID: 37605344
[TBL] [Abstract][Full Text] [Related]
17. Lymphoplasmacytic Lymphoma and Marginal Zone Lymphoma.
Juárez-Salcedo LM; Castillo JJ
Hematol Oncol Clin North Am; 2019 Aug; 33(4):639-656. PubMed ID: 31229160
[TBL] [Abstract][Full Text] [Related]
18. Nodal marginal zone lymphoma: Clinical features, diagnosis, management and treatment.
Tadmor T; Polliack A
Best Pract Res Clin Haematol; 2017; 30(1-2):92-98. PubMed ID: 28288722
[TBL] [Abstract][Full Text] [Related]
19. [Current management of marginal zone lymphomas].
Bonnet C; Lejeune M; Van Kemseke C; Bron D; Beguin Y
Rev Med Suisse; 2015 Aug; 11(483):1549-56. PubMed ID: 26502581
[TBL] [Abstract][Full Text] [Related]
20. Marginal zone lymphoma in elderly and geriatric patients.
Goede V
Best Pract Res Clin Haematol; 2017; 30(1-2):158-165. PubMed ID: 28288711
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
